Comments

SpringWorks Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does SpringWorks Therapeutics (SWTX) operate in?

SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SWTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$47.21

-1.30-2.68%

At close: -

$47.30

0.090.19%

After Hours: 5:49 PM EDT

SpringWorks Therapeutics (SWTX) Forecast

News Earnings SpringWorks Therapeutics (SWTX) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

SpringWorks Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SWTX | Benzinga

Explore SpringWorks Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SWTX.

Open	$48.51
Close	$47.21
Volume / Avg.	1.41M / 2.39M
Day Range	$46.98 - $48.62
52 Wk Range	28.21 - 62.00
Market Cap	$3.54B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	11.46%
Days to Cover	2.4

Recent News

Top 3 Health Care Stocks You May Want To Dump In February

Avi Kapoor

WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?

Top performing mid-cap stocks last week: WRD (+97.62%), GDS (+43.45%), SWTX (+42.58%), RXRX (+40.59%), SOC (+39.09%), WGS (+28.23%), VNET (+28.22%), NSP (+25.99%), CRSP (+25.21%), AXSM (+24.01%)

Lekha Gupta

SpringWorks Therapeutics Secures FDA Approval For Second Cancer Drug

SpringWorks' Gomekli wins FDA approval for NF1-related tumors, showing strong efficacy in trials. U.S. launch expected in two weeks, with EU review ongoing.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$48.51
Close	$47.21
Volume / Avg.	1.41M / 2.39M
Day Range	$46.98 - $48.62
52 Wk Range	28.21 - 62.00
Market Cap	$3.54B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	11.46%
Days to Cover	2.4

About SpringWorks Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medi...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SpringWorks Therapeutics (SWTX) stock?

You can purchase shares of SpringWorks Therapeutics (NASDAQ:SWTX) through any online brokerage.

View our list of the best stock brokerages

Who are SpringWorks Therapeutics (SWTX) competitors?

Other companies in SpringWorks Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Ionis Pharmaceuticals (NASDAQ:IONS) and Alkermes (NASDAQ:ALKS).

What is the forecast, or price target, for SpringWorks Therapeutics (SWTX) stock?

SpringWorks Therapeutics has a consensus price target of $65.25.

What is the current price for SpringWorks Therapeutics (SWTX)?

The stock price for SpringWorks Therapeutics (NASDAQ: SWTX) is $47.3 last updated March 25, 2025 at 5:49 PM EDT.

Does SpringWorks Therapeutics (SWTX) pay a dividend?

There are no upcoming dividends for SpringWorks Therapeutics.

When is SpringWorks Therapeutics (NASDAQ:SWTX) reporting earnings?

SpringWorks Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is SpringWorks Therapeutics (SWTX) going to split?

There is no upcoming split for SpringWorks Therapeutics.

What sector and industry does SpringWorks Therapeutics (SWTX) operate in?

SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.